Drugs / Gonyautoxin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00276952 | Sep 2004 → Aug 2005 | — | University of Chile | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03025594 | Jan → Aug 2017 | osteoarthritis, knee | maximiliano barahona vasquez | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gonyautoxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03025594 ↗ |
| Action | Inhibit | “reversible block of the voltage-gated sodium channels” NCT00276952 ↗ |
| Modality | Other / unclassified | “Gonyautoxin are phycotoxins” NCT00276952 ↗ |
| Route | Other | “the patients were locally injected with placebo versus Gonyautoxin following a painful spots injection standarized protocol” NCT00276952 ↗ |